FdaApplication
ANDA 210032
Identifiers
- fda_app_no: ANDA210032
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2019-08-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | 0.2055MG/SPRAY | SPRAY, METERED;NASAL |
1 product